Technology helps patients’ battle heart failure: BIOAXIS Healthcare Portugal’s role in a novel cooperative targeting patients suffering from heart failure.
BIOAXIS Healthcare Ltd, a recognized EU patient adherence expert, announced that its’ Portuguese subsidiary Caredome Patient Support and Healthcare Solutions will play a contributing role to a novel cooperative strategy focused on the mHEALTH environment, targeting patients suffering from heart failure, with the goal of achieving improved patient adherence & patient management.
The respective project has been awarded to BIOAXIS Healthcare Portugal (Caredome Patient Support and Healthcare Solutions) in partnership with participating Universities and other firms across Europe and is a response to the European Commission Horizon 2020 call, entitled “HEARTEN”. Horizon 2020 is the biggest EU Research and Innovation program to date, with nearly €80 billion in funding to be available over a 7 year period (being, 2014 to 2020).
The cooperative involves the participation of notable universities and companies from 5 major European countries in addition to BIOAXIS Healthcare Portugal, being Claude Bernard Lyon 1 University & the Lyon Ingénierie Projets (France), Everis SL & El Servicio Andaluz de Salud as well as the CSIC (Spain), University of Pisa & Your Data SRL as well as the SESANV Group (Italy), Appart SA & the Foundation of Research & Technology Hellas - FORTH (Greece) & Universitätsmedizin Rostock (Germany). This cooperative passed the tender process with flying colours, achieving the highest rating of all applications.
HEARTEN will design, develop & validate an ICT co-operative environment that will enable Heart Failure patients to achieve sustainable behavior change regarding their adherence, & the ecosystem actors to be engaged & to improve the patients’ management. HEARTEN targets all stakeholders related to the management of patients suffering from Heart Failure, including healthcare professionals, caregivers, healthcare providers nutritionists, fitness experts & health insurance experts, towards developing a multi-stakeholder patient centered mHEALTH ecosystem.
Using biosensors to detect & measure specific biomarkers, & communicating these through smart phone technology to the HEARTEN cloud architecture where a knowledge management system analyses the data & delivers critical information to the patient, the Heart Failure patients are empowered with the capacity for self-management.
Heart Failure is a cardiovascular chronic disease increasing at an exponential rate & it is the main cause of mortality & poor quality of life in western societies. According to the European Heart Failure Association, 26 million people experience Heart Failure globally and 3.6 million people are diagnosed with Heart Failure, annually.
Mr. Vassilis Triantopoulos, CEO of BIOAXIS Healthcare announced: “We are pleased to contribute to such a meaningful project with all our cooperative partners. Giving Heart Failure patients the ability to self-manage their condition, hence gain independence & greater freedom while also achieving greater prevention & timely diagnoses, would be an invaluable achievement. We are proud to be a part of it.”
BIOAXIS Healthcare is a leading company offering patient management & support services. The company currently has a presence in Greece & Cyprus, Portugal & the UK. Given its pioneering spirit, it is the only company that offers certified cold-chain drug delivery & logistics services to its clients in accordance with the strictest GDP guidelines in selected countries of operation. Furthermore, as a strategic initiative it has turned its attention to the offer of holistic e- health solutions that aim to satisfy the modern-day needs of its clients. BIOAXIS Healthcare consistently manages & supports thousands of patients every year on behalf of leading pharmaceutical & other healthcare companies.